Insiders · Profile

Behrenbruch Christian

MD & Group CEO at Telix Pharmaceuticals. Filing since 28 Apr 2026. CIK 0002037713

Company

Date

Role

Action

Amount

Of holding

29 Apr 2026

MD & Group CEO

Bought

33,435

$497.18K

0.2%

28 Apr 2026

MD & Group CEO

Bought

34,500

$499.56K

0.2%

2 decisions on file.